Back
Outlook Therapeutics Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
25
OTLK
Outlook Therapeutics
Last Price:
6.01
Seasonality Move:
-12.63%
7 Day Trial
ALL ACCESS PASS
$
7
How to Build the Ultimate Dividend Portfolio
See how to build your own Ultimate Dividend PortfolioOutlook Therapeutics Price Quote
$6.01
+0.26 (+4.52%)
(Updated: November 1, 2024 at 2:20 PM ET)
Outlook Therapeutics Key Stats
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Day range:
$5.68 - $5.85
52-week range:
$4.61 - $12.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.60
P/B ratio:
0%
Volume:
136.2K
Avg. volume:
282.8K
1-year change:
-52.08%
Market cap:
$136M
Revenue:
$0
EPS:
$-10.77
How Much Does Outlook Therapeutics Make?
Data Unavailable
Is Outlook Therapeutics Growing As A Company?
Data Unavailable
Outlook Therapeutics Stock Price Performance
-
Did Outlook Therapeutics Stock Go Up Last Month?
Outlook Therapeutics share price went up by 7.68% last month -
Did OTLK's Share Price Rise Over The Last Year?
OTLK share price fell by -52.08% over the past 1 year
What Is Outlook Therapeutics 52-Week High & Low?
-
What Is Outlook Therapeutics’s 52-Week High Share Price?
Outlook Therapeutics has traded as high as $12.85 over the past 52 weeks -
What Is Outlook Therapeutics’s 52-Week Low Share Price?
Outlook Therapeutics has traded as low as $4.61 over the past 52 weeks
Outlook Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Outlook Therapeutics?
-
How Much Debt Does Outlook Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Outlook Therapeutics Have?
Cash and short term investments quarterly total is $32M -
What Is Outlook Therapeutics’s Book Value Per Share?
Book value per share is -3.57
Is Outlook Therapeutics Cash Flow Positive?
-
What Is OTLK Cash Flow From Operations?
Cash flow from operations (TTM) is -$64.6M -
What Is Outlook Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $62.9M -
What Is Outlook Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Outlook Therapeutics Return On Invested Capital
Data Unavailable
Outlook Therapeutics Earnings Date & Stock Price
-
What Is Outlook Therapeutics's Stock Price Today?
A single share of OTLK can be purchased today for 5.75 -
What Is Outlook Therapeutics’s Stock Symbol?
Outlook Therapeutics trades on the nasdaq under the ticker symbol: OTLK -
When Is Outlook Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Outlook Therapeutics is scheduled on December 20, 2024 -
When Is OTLK's next ex-dividend date?
Outlook Therapeutics's next ex-dividend date is May 15, 2020 -
How To Buy Outlook Therapeutics Stock?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Outlook Therapeutics Competitors
-
Who Are Outlook Therapeutics's Competitors?
Below is a list of companies who compete with Outlook Therapeutics or are related in some way:
Outlook Therapeutics Dividend Yield
-
What Is OTLK Dividend Yield?
Outlook Therapeutics’s dividend yield currently is 0% -
What Is Outlook Therapeutics’s Payout Ratio?
Outlook Therapeutics’s payout ratio is 0% -
When Did Outlook Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Outlook Therapeutics’s Dividend Per Share?
Outlook Therapeutics pays a dividend of $0.00 per share
Outlook Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -43.79% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 37.43 |
| Upside from Last Price: | 550.93% |